
Robin Hood Ventures
Description
Robin Hood Ventures is a prominent angel investor group based in Philadelphia, Pennsylvania, with a strong focus on early-stage, high-growth companies primarily within the Greater Philadelphia region and the broader Mid-Atlantic. Established over two decades ago, the group has built a reputation for identifying and nurturing promising startups across various sectors, including software, healthcare IT, biotech, and advanced materials. Their investment philosophy emphasizes not just capital infusion but also active mentorship and strategic guidance, leveraging the collective experience of their diverse angel network to support portfolio companies through critical growth phases.
The group typically participates in seed and Series A funding rounds, offering initial checks that range from $250,000 to $1,000,000. These investments are often part of larger syndicates, where Robin Hood Ventures co-invests alongside other angel groups, venture capital firms, and institutional investors. This collaborative approach allows them to support more substantial funding rounds while maintaining their focus on early-stage opportunities. Their commitment to the local ecosystem is evident in their consistent investment activity within the region, contributing significantly to the development of the Philadelphia startup landscape.
Over its more than 20 years of operation, Robin Hood Ventures has invested in over 100 companies, demonstrating a sustained commitment to fostering innovation and economic growth. Their long-standing presence and extensive portfolio underscore their deep understanding of the challenges and opportunities faced by nascent businesses. By providing crucial early capital and hands-on support, Robin Hood Ventures plays a vital role in helping promising startups scale, attract follow-on funding, and ultimately achieve market success.
Investor Profile
Robin Hood Ventures has backed more than 148 startups, with 10 new investments in the last 12 months alone. The firm has led 13 rounds, about 9% of its total and boasts 14 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Convertible Note, Series A rounds (top funding stages).
- Majority of deals are located in United States, Israel, Canada.
- Strong thematic focus on Health Care, Biotechnology, Software.
- Led 1 rounds in the past year.
- Typical check size: $250K – $1M.
Stage Focus
- Seed (26%)
- Convertible Note (18%)
- Series A (18%)
- Series Unknown (14%)
- Series B (7%)
- Undisclosed (5%)
- Series C (3%)
- Debt Financing (3%)
- Pre Seed (2%)
- Angel (1%)
Country Focus
- United States (96%)
- Israel (3%)
- Canada (1%)
Industry Focus
- Health Care
- Biotechnology
- Software
- Medical
- Therapeutics
- Medical Device
- E-commerce
- Life Science
- Information Technology
- Artificial Intelligence (Ai)
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.